Title: Dendritic cell immunotherapy in uterine cancer
Authors: Coosemans, An * ×
Tuyaerts, Sandra *
Vanderstraeten, Anke
Vergote, Ignace
Amant, Frédéric
Van Gool, Stefaan #
Issue Date: 30-Apr-2014
Publisher: Landes Bioscience
Series Title: Human Vaccines & Immunotherapeutics vol:10 issue:7 pages:1822-1827
Abstract: Uterine cancer is the most common pelvic gynecological malignancy. Uterine sarcomas and relapsed uterine carcinomas have limited treatment options. The search for new therapies is urgent. Dendritic cell (DC) immunotherapy holds much promise, though has been poorly explored in uterine cancer. This commentary gives an insight in existing DC immunotherapy studies in uterine cancer and summarizes the possibilities and the importance of the loading of tumor antigens onto DC and their subsequent maturation. However, the sole application of DC immunotherapy to target uterine cancer will be insufficient because of tumor-induced immunosuppression, which will hamper the establishment of an effective anti-tumor immune response. The authors give an overview on the limited existing immunosuppressive data and propose a novel approach on DC immunotherapy in uterine cancer.
ISSN: 2164-5515
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gynaecological Oncology
Laboratory of Pediatric Immunology
* (joint) first author
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Coosemans 2014_DC immunotherapy uterine cancer.pdfOA article Accepted 130KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science